% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Tsiouris:132866,
author = {A. Tsiouris$^*$ and N. Ungar and A. Haussmann$^*$ and M.
Sieverding and K. Steindorf$^*$ and J. Wiskemann$^*$},
title = {{H}ealth {C}are {P}rofessionals' {P}erception of
{C}ontraindications for {P}hysical {A}ctivity {D}uring
{C}ancer {T}reatment.},
journal = {Frontiers in oncology},
volume = {8},
issn = {2234-943X},
address = {Lausanne},
publisher = {Frontiers Media},
reportid = {DKFZ-2018-00509},
pages = {98},
year = {2018},
abstract = {Suggested medical contraindications for physical activity
(PA) during cancer therapy might have an influence on PA
recommendation behavior of Health Care Professionals (HCP).
The purpose of the present study was to examine perceptions
of physicians and oncology nurses (ON) toward specific
medical conditions as contraindications for PA during cancer
treatment.A total of 539 physicians and 386 ON were enrolled
in this cross-sectional survey. HCP judged 13 medical
conditions as to whether they are contraindications for PA
during cancer treatment. Answering format was 'no
contraindication'/'potentially a contraindication'/'yes, a
contraindication.'χ2 analyses revealed significant
differences between general practitioners, specialized
physicians, and ON in their perception of 10 medical
conditions. Approximately half of the medical conditions
were answered cautiously, showing high numbers on the
response option potentially $(36-72\%).$ Moreover,
physicians' ratings differed significantly depending on
their practical experience with particular medical
conditions. Those being familiar with a specific medical
condition was more permissive to PA during treatment, with
effect sizes (Cramer's V) ranging from 0.13 to 0.27.Results
indicate high cautiousness among HCP in judging medical
conditions and their impact on PA during cancer treatment.
However, group comparisons show that familiarity and
clinical experience with potential contraindications
facilitate a confident handling of safety issues, which at
best leads to higher levels of PA recommendations during
cancer treatment.},
cin = {G210},
ddc = {610},
cid = {I:(DE-He78)G210-20160331},
pnm = {317 - Translational cancer research (POF3-317)},
pid = {G:(DE-HGF)POF3-317},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29670858},
pmc = {pmc:PMC5894008},
doi = {10.3389/fonc.2018.00098},
url = {https://inrepo02.dkfz.de/record/132866},
}